Bio-Rad Laboratories BIO SEC Filings

NYSE BIO
$377.07 -3.05 (-0.80%)
As of: Sep 9, 2026 · 11:22 AM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Bio-Rad Laboratories, Inc. (BIO) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index